Wyeth Pharmaceuticals Company, Inc. | Pfizer | water pollution violation | 2010 | EPA | $77,000 |
Merck and Company | Merck | water pollution violation | 2008 | EPA | $6,075,000 |
Pernix Therapeutics, LLC | Currax Pharmaceuticals | WARN Act violation | 2019 | private lawsuit-federal | $300,000 |
Block Drug Company Incorporated | GlaxoSmithKline | wage and hour violation | 2011 | WHD | $352,773 |
St Jude Medical Inc | Abbott Laboratories | wage and hour violation | 2009 | WHD | $17,662 |
Abbott Laboratories Puerto Rico, Inc. | Abbott Laboratories | wage and hour violation | 2009 | WHD | $49,045 |
Biogen Idec, Inc. | Biogen | wage and hour violation | 2009 | WHD | $49,600 |
Wyeth Biopharma | Pfizer | wage and hour violation | 2005 | WHD | $40,187 |
Biogen Idec Inc. | Biogen | wage and hour violation | 2005 | WHD | $6,934 |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | wage and hour violation | 2004 | WHD | $160,203 |
Valmed Pharmaceutical, Inc. | Teva Pharmaceutical Industries | wage and hour violation | 2004 | WHD | $83,871 |
Alere San Diego Inc. | Abbott Laboratories | wage and hour violation | 2017 | WHD | $10,572 |
Amphastar Pharmaceuticals | Amphastar Pharmaceuticals | wage and hour violation | 2011 | CA-LCO | $25,000 |
General Nutrition Corporation | Harbin Pharmaceutical Group | wage and hour violation | 2017 | MA-AG | $72,304 |
Synthes USA | Johnson & Johnson | wage and hour violation | 2016 | private lawsuit-federal | $5,000,000 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2016 | private lawsuit-federal | $9,000,000 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2015 | private lawsuit-federal | $350,014 |
Mylan | Viatris | wage and hour violation | 2014 | private lawsuit-federal | $225,000 |
Novartis | Novartis | wage and hour violation | 2012 | private lawsuit-federal | $99,000,000 |
Genentech | Roche | wage and hour violation | 2012 | private lawsuit-state | $2,100,000 |
Genentech | Roche | wage and hour violation | 2011 | private lawsuit-state | $2,600,000 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2007 | private lawsuit-federal | $1,910,000 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2005 | private lawsuit-federal | $60,000 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2005 | private lawsuit-state | $4,600,000 |
Pharmavite LLC | Otsuka Pharmaceutical | wage and hour violation | 2017 | private lawsuit-state | $1,925,000 |
Mallinckrodt Enterprises, LLC | Mallinckrodt | wage and hour violation | 2018 | WHD | $54,805 |
Baxalta US Inc. | Takeda Pharmaceutical | wage and hour violation | 2019 | private lawsuit-state | $4,750,000 |
Depuy Synthes Sales, Inc. | Johnson & Johnson | wage and hour violation | 2020 | CA-LCO | $57,488 |
Allergan Inc | AbbVie | wage and hour violation | 2019 | MI-LEO | $7,656 |
Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | wage and hour violation | 2018 | MI-LEO | $12,500 |
Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | wage and hour violation | 2018 | MI-LEO | $5,070 |
Allergan Usa Inc | AbbVie | wage and hour violation | 2017 | MI-LEO | $64,828 |
Allergan Plc | AbbVie | wage and hour violation | 2016 | MI-LEO | $73,999 |
Allergan Usa Inc | AbbVie | wage and hour violation | 2016 | MI-LEO | $73,999 |
Novartis Pharmaceuticals Corporation | Novartis | wage and hour violation | 2014 | MI-LEO | $13,000 |
Novartis Pharmaceuticals Corporation | Novartis | wage and hour violation | 2014 | MI-LEO | $5,885 |
AKORN OPERATING COMPANY LLC | Akorn Inc. | wage and hour violation | 2023 | IL-DOL | $13,000 |
AKORN OPERATING COMPANY LLC | Akorn Inc. | wage and hour violation | 2023 | IL-DOL | $10,600 |
Akorn Inc | Akorn Inc. | wage and hour violation | 2023 | IL-DOL | $15,000 |
ABBVIE INC | AbbVie | wage and hour violation | 2022 | IL-DOL | $27,330 |
Akorn Inc | Akorn Inc. | wage and hour violation | 2022 | IL-DOL | $7,000 |
ABBVIE US LLC | AbbVie | wage and hour violation | 2021 | IL-DOL | $25,973 |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | tax violations | 2014 | ATTTB | $506,035 |
Aldrich Chemical Company LLC | Merck KGaA (EMD) | tax violations | 2017 | ATTTB | $22,500 |
GlaxoSmithKline Holdings (Americas) | GlaxoSmithKline | tax violations | 2006 | IRS | $3,400,000,000 |
Merck & Co., Inc. | Merck | tax violations | 2007 | IRS | $2,300,000,000 |
PHIBRO-TECH, INC. | Phibro Animal Health | railroad safety violation | 2008 | FRA | $5,650 |
Mallinckrodt | Mallinckrodt | railroad safety violation | 2007 | FRA | $10,000 |
Pfizer Inc. | Pfizer | railroad safety violation | 2002 | FRA | $11,250 |
Phibro-Tech Inc. | Phibro Animal Health | railroad safety violation | 2006 | FRA | $6,800 |
Cherokee Pharmaceuticals | Merck | railroad safety violation | 2021 | FRA | $5,000 |
Malincrodt Chemical Company | Mallinckrodt | railroad safety violation | 2022 | FRA | $7,500 |
Mallinckrodt, Inc. | Mallinckrodt | radioactive waste violation | 2008 | GA-ENV | $5,000 |
Johnson & Johnson | Johnson & Johnson | product safety violation | 2021 | private lawsuit-federal | $2,500,000,000 |
Daiichi Sankyo Inc. | Daiichi Sankyo | product safety violation | 2017 | private lawsuit-federal | $300,000,000 |
Endo Health Solutions Inc. | Endo International | product safety violation | 2017 | private lawsuit-federal | $15,500,000 |
Teva Pharmaceuticals Industries Ltd. | Teva Pharmaceutical Industries | product safety violation | 2012 | private lawsuit-federal | $270,000,000 |
Janssen Pharmaceuticals, Inc. | Johnson & Johnson | product safety violation | 2022 | private lawsuit-federal | $150,000,000 |
Johnson & Johnson | Johnson & Johnson | product safety violation | 2023 | private lawsuit-federal | $8,900,000,000 |
Eli Lilly & Co. | Eli Lilly | privacy violation | 2002 | MULTI-AG | $160,000 |
CSL Plasma Inc. | CSL Limited | privacy violation | 2022 | private lawsuit-federal | $9,900,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2015 | FTC | $1,200,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2009 | FTC | $2,100,000 |
Alpharma, Inc. | Pfizer | price-fixing or anti-competitive practices | 2004 | FTC | $2,500,000 |
Perrigo Company | Perrigo | price-fixing or anti-competitive practices | 2004 | FTC | $3,750,000 |
Hoechst AG | Sanofi | price-fixing or anti-competitive practices | 2003 | DOJ_ANTITRUST | $12,000,000 |
Merck KgaA | Merck KGaA (EMD) | price-fixing or anti-competitive practices | 2000 | DOJ_ANTITRUST | $14,000,000 |
Mallinckrodt ARD Inc | Mallinckrodt | price-fixing or anti-competitive practices | 2017 | FTC | $100,000,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2010 | MULTI-AG | $22,500,000 |
Alpharma, Inc. | Pfizer | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
Amphastar Pharmaceuticals, Inc. | Amphastar Pharmaceuticals | price-fixing or anti-competitive practices | 2015 | MA-AG | $325,000 |
Andrx Corporation | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $40,000,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $40,000,000 |
Aventis Pharmaceuticals, Inc. | Sanofi | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $1,650,000 |
Barr Pharmaceuticals | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $5,900,000 |
Bausch & Lomb | Bausch Health | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $17,500,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $55,000,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $100,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $1,100,000 |
CIBA Vision | Novartis | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $5,000,000 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $4,340,100 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2000 | CA-AG | $1,446,700 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Eisai | Eisai | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $7,634,700 |
Eisai Co. | Eisai | price-fixing or anti-competitive practices | 2000 | CA-AG | $2,544,900 |
Eisai Co. | Eisai | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Endo International plc | Endo International | price-fixing or anti-competitive practices | 2019 | MULTI-AG | $2,300,000 |
Geneva Pharmaceuticals | Novartis | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $70,000,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $14,000,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $3,500,000 |
Hoffman-LaRoche | Roche | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $142,494,000 |
Hoffman-LaRoche | Roche | price-fixing or anti-competitive practices | 2000 | CA-AG | $47,498,000 |
Hoffman-LaRoche | Roche | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $60,000,000 |
Mallinckrodt plc | Mallinckrodt | price-fixing or anti-competitive practices | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $100,000,000 |
Merck KGaA | Merck KGaA (EMD) | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
Mylan Laboratories et al. | Viatris | price-fixing or anti-competitive practices | 2000 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000 |
Organon USA Inc | Organon & Co. | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $36,000,000 |
Perrigo Company | Perrigo | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |